Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 4/20 | 0.45 |
| ▸ | MCHR1 | Q99705 | 3/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 4/20 | 0.39 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | ATXN2 | Q99700 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30700465 | 0.88 | MGLL (0.47) | MGLLLIPGENPP2ATXN2 | |
| SCHEMBL30700801 | 0.88 | MGLL (0.47) | MGLLLIPGENPP2ATXN2 | |
| SCHEMBL27288877 | 0.88 | MGLL (0.47) | MGLLLIPGENPP2ATXN2 | |
| SCHEMBL30699866 | 0.87 | MGLL (0.45) | MGLLMCHR1PDK2NOTUMLIPG | |
| SCHEMBL30700318 | 0.82 | MGLL (0.45) | MGLLLIPGENPP2ATXN2 | |
| SCHEMBL30700026 | 0.81 | MGLL (0.44) | MGLLLIPGENPP2ATXN2 | |
| SCHEMBL30700507 | 0.80 | MGLL (0.44) | MGLLCYP11B1CYP11B2LIPGENPP2 | |
| SCHEMBL30700153 | 0.80 | MGLL (0.44) | MGLLCYP11B1CYP11B2LIPGENPP2 | |
| SCHEMBL30700038 | 0.80 | MGLL (0.44) | MGLLLIPGENPP2ATXN2 | |
| SCHEMBL30700493 | 0.79 | MGLL (0.41) | MGLLLIPGENPP2ATXN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543870-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2025-04-30 | — | — | EP | claimed |
| CN-119301113-A | Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors | 豪夫迈·罗氏有限公司 | 2025-01-10 | — | — | CN | claimed |
| WO-2023247670-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-12-28 | — | — | WO | claimed |
| CN-119301113-A | Novel heterocyclic carbonyl cyclic compounds as MAGL inhibitors | 豪夫迈·罗氏有限公司 | 2025-01-10 | — | — | CN | disclosed |
| WO-2023247670-A1 | NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2023-12-28 | — | — | WO | disclosed |